Systematic review / meta-analysis / 2021
Caffeinated coffee consumption was inversely associated with risk of CVD, type 2 diabetes, endometrial cancer, melanoma, and nonmelanoma skin cancer.
A dose-response meta-analysis of prospective studies evaluated caffeinated coffee intake and select health outcomes. In any coffee consumers, there was a significant inverse association with the risk of CVD (RR = 0.90; 95% CI: 0.84, 0.96), T2D (RR = 0.90; 95% CI: 0.85, 0.96), endometrial cancer (RR = 0.85; 95% CI: 0.78, 0.92), melanoma (RR = 0.89; 95% CI: 0.80, 0.99), and nonmelanoma skin cancer (RR = 0.92; 95% CI: 0.89, 0.95). Consumption was also inversely associated with HCC without reaching statistical significance (RR = 0.93; 95% CI: 0.80, 1.08). The dose-response relation was nonlinear uniquely for CVD (P-nonlinearity = 0.01), with the largest risk reduction observed for 3-4 cups/d and no reduction thereafter, whereas risk decreased linearly for other outcomes.
Shows an association, not proof of cause and effect.
- Study type
- Dose-response meta-analysis of prospective studies
- Who was studied
- 3,713,932 participants (42 distinct cohorts from 26 studies, with 93,706 cases/deaths)
- What was measured
- Incidence/mortality of CVD, and incidence of T2D, HCC, endometrial cancer, melanoma, and nonmelanoma skin cancer
THE PAPER
Caffeinated Coffee Consumption and Health Outcomes in the US Population: A Dose-Response Meta-Analysis and Estimation of Disease Cases and Deaths Avoided.
Di Maso M, Boffetta P, Negri E, La Vecchia C, Bravi F. Adv Nutr, 2021.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.